Indole-3-Carbinol (I3C).

Indole-3-carbinol condenses in stomach acid to form DIM, which is the main species that actually reaches circulation. Supplying both means one formula carries the precursor and the stable end product of the same pathway.

DIM is the acid condensation product of indole-3-carbinol, so the two occupy the same route with DIM at the downstream end. Combining them covers variable stomach acidity.

The conversion of indole-3-carbinol into DIM and related oligomers needs gastric acid, so low stomach acidity leaves more of the parent compound unconverted. Betaine HCl is used in formulas to keep that condensation step supplied.

Indole-3-carbinol shifts oestrogen hydroxylation toward the 2-hydroxy route in phase one, while calcium D-glucarate slows gut beta-glucuronidase so glucuronidated conjugates stay bound for excretion. The two act at different points of the same clearance sequence.

Both come from glucosinolate breakdown and both raise Nrf2-driven phase two conjugating enzymes, with indole-3-carbinol additionally acting on the aryl hydrocarbon receptor and phase one. The pair covers both arms of the same sequence.

Glucoraphanin is the sulforaphane precursor while glucobrassicin is the indole-3-carbinol precursor, and both need myrosinase or gut bacteria to release the active form. They sit side by side in cruciferous formulas covering different products of the same enzyme step.

Myrosinase hydrolyses glucobrassicin to the unstable indole that becomes indole-3-carbinol, so an active myrosinase source raises yield from a glucosinolate ingredient. Heat-processed extracts lose that enzyme and depend on gut bacteria instead.

Glucobrassicin is the intact glucosinolate that yields indole-3-carbinol once myrosinase cleaves it. A formula carrying both supplies the finished compound plus a slower-release reservoir.

Cruciferous glucosinolate extracts carry the indole and aliphatic precursors together, so they overlap with an isolated indole-3-carbinol dose. Counting the combined indole load matters when both appear in one formula.

Indole-3-carbinol and its condensation products induce CYP1A2, the enzyme that clears most caffeine, so the same caffeine dose is metabolised faster and its effect can feel shorter. This is an induction interaction rather than a competitive one.

Glutathione is the conjugating substrate for the glutathione S-transferases that indole-3-carbinol condensation products induce through the aryl hydrocarbon receptor. Inducing the enzyme without supporting the substrate pool is half of the system. Oral glutathione absorption is contested, which is why precursor amino acids are often used instead. The enzymatic dependency itself is not in question.

N-acetylcysteine delivers cysteine, the rate-limiting amino acid for glutathione synthesis, in a form stable enough to survive the gut. Phase II conjugation induced by indole chemistry draws directly on that glutathione pool. The relationship is a defined precursor-to-product step rather than a general antioxidant argument. It is the most direct way to support the substrate side.

Glutathione is assembled from glutamate, cysteine and glycine, and glycine supply becomes limiting in some people. Indole-driven induction of glutathione S-transferase raises turnover of that tripeptide. Supplying the third amino acid completes the precursor set alongside cysteine. This is textbook synthesis biochemistry.

5-methyltetrahydrofolate donates the methyl group that regenerates methionine from homocysteine, feeding the S-adenosylmethionine pool. Catechol-O-methyltransferase draws on that pool to methylate the 2-hydroxyoestrogen metabolites that indole-3-carbinol chemistry produces more of. Folate status therefore governs the clearance half of the pathway. The link is metabolic and needs no trial to state.

S-adenosylmethionine is the universal methyl donor and the direct cosubstrate for catechol-O-methyltransferase. The 2-hydroxylated catechol metabolites favoured by indole chemistry are cleared by exactly that enzyme. Supplying SAM-e feeds the cosubstrate directly rather than through the regeneration cycle. Note that SAM-e has its own considerations alongside serotonergic medicines.

Methionine synthase requires methylcobalamin to transfer the folate-borne methyl group to homocysteine. Without adequate B12 the folate cycle stalls in the methylfolate trap and S-adenosylmethionine regeneration falls. The catechol methylation step downstream of indole chemistry depends on that regeneration. This is one of the clearest cofactor dependencies in the whole sequence.

Trimethylglycine remethylates homocysteine independently of folate through betaine-homocysteine methyltransferase, giving a second route to the methyl donor pool. That pool is what methylates the catechol oestrogen metabolites produced downstream. Betaine is useful precisely where folate handling is constrained. This is anhydrous betaine, not the hydrochloride salt used for gastric acidity.

Choline is oxidised in the liver and kidney to betaine, which then donates a methyl group to homocysteine. It therefore feeds the same methyl donor pool the catechol methylation step depends on, one step further back. Choline intake is commonly below adequate intake figures in general diets. The pathway link is settled biochemistry.

Pyridoxal 5-phosphate is the cofactor for cystathionine beta-synthase and cystathionine gamma-lyase, the transsulfuration route that converts homocysteine into cysteine for glutathione synthesis. Indole-driven phase II induction increases demand on that glutathione. B6 status determines how much homocysteine can be routed toward cysteine rather than remethylated. The dependency is enzymatic and absolute.

Riboflavin becomes FAD, which is the cofactor for NADPH-cytochrome P450 reductase and for methylenetetrahydrofolate reductase. Indole-3-carbinol condensation products induce CYP1A enzymes that cannot turn over without an adequately flavinated reductase partner. Riboflavin status therefore constrains both the phase I and the folate side of the picture. It is rarely considered alongside this ingredient.

Catechol-O-methyltransferase is a magnesium-dependent enzyme; the divalent cation coordinates the catechol substrate in the active site. Indole-3-carbinol chemistry increases the supply of catechol oestrogen substrates for that enzyme. Magnesium status is therefore part of the clearance step and not merely a general nutrient. The cofactor requirement is a structural feature of the enzyme.

Selenocysteine sits at the active site of glutathione peroxidase and thioredoxin reductase, the enzymes that use reduced glutathione to manage peroxides. Phase I induction generates reactive intermediates that this machinery handles. Indole chemistry moves phase I and phase II together, so both the generation and the handling sides are engaged. Selenium status sets the capacity of the handling side.

Dihydrolipoic acid regenerates oxidised glutathione, vitamin C and indirectly vitamin E, keeping the cellular redox pool in usable form. Indole-driven conjugation draws on that pool. Recycling is a different contribution from synthesis, so lipoic acid is not redundant with the amino acid precursors. It distributes into both aqueous and lipid compartments.

Silymarin flavonolignans are described in preclinical work as supporting hepatic glutathione status and as modulating several biotransformation enzymes. Indole-3-carbinol reaches an overlapping enzyme set through the aryl hydrocarbon receptor. Two different entry points onto shared hepatic machinery. That shared machinery also handles medicines, so the pairing is not neutral for anyone on prescription therapy.

Curcumin activates Nrf2, which transcribes the phase II battery including glutathione S-transferases and NAD(P)H quinone oxidoreductase 1. Indole-3-carbinol reaches part of that same output through aryl hydrocarbon receptor signalling. Two transcription factors converging on an overlapping gene set is the mechanistic basis for the pairing. Curcumin needs a lipid or piperine aid to absorb meaningfully.

EGCG inhibits catechol-O-methyltransferase in laboratory systems, the enzyme that clears the 2-hydroxyoestrogen metabolites indole chemistry generates more of. A substrate-raising agent combined with an inhibitor of the clearing enzyme is a directional interaction, not a straightforward addition. The observation sits at the in vitro level and has not been measured as a combination in people. Direction is the useful thing to record.

Quercetin inhibits several sulfotransferase and glucuronosyltransferase isoforms in vitro while also being a substrate for them. Indole-3-carbinol shifts phase I and phase II balance in the same hepatic compartment. Whether clearance of a given metabolite rises or falls depends on which isoform dominates it. Mechanism alone does not predict the net direction here.

Resveratrol inhibits CYP1A1 and CYP1B1 in cell systems, the same enzymes that indole-3-carbinol condensation products induce through the aryl hydrocarbon receptor. That is direct opposition at one enzyme family. Anyone stacking them is not simply adding two favourable agents. No human data addresses the combination.

Gut bacteria convert dietary tryptophan into indole metabolites that are themselves aryl hydrocarbon receptor ligands, so the microbiota supplies a continuous background signal at the receptor this compound acts on. A supplement adds to that existing load rather than acting on a quiet receptor. Background varies considerably between individuals. Strain identity matters more than the general category label.

Broccoli sprouts carry glucobrassicin, which yields indole-3-carbinol, alongside glucoraphanin, which yields sulforaphane. The two breakdown products act through different receptors, the aryl hydrocarbon receptor and Nrf2 respectively. A whole sprout extract delivers them in something close to their plant ratio. Adding an indole isolate shifts that ratio toward the indole side.

Cysteine is the rate-limiting input to glutathione synthesis, the pool that phase II conjugation enzymes consume. Indole condensation products induce those enzymes. Free cysteine oxidises readily in solution, which is why it is usually supplied as N-acetylcysteine or from a whey source. The precursor relationship itself is settled.

Whole cruciferous preparations yield thiocyanate and goitrin from glucosinolates other than glucobrassicin, and thiocyanate competes with iodide at the sodium-iodide symporter. A purified indole-3-carbinol isolate does not carry those compounds, so the concern belongs to whole-vegetable concentrates rather than to the isolate. Iodine sufficiency determines whether the competition has any practical weight. The isolate versus concentrate distinction is the point worth carrying.